314 related articles for article (PubMed ID: 9473218)
1. Protein C inhibitor acts as a procoagulant by inhibiting the thrombomodulin-induced activation of protein C in human plasma.
Elisen MG; von dem Borne PA; Bouma BN; Meijers JC
Blood; 1998 Mar; 91(5):1542-7. PubMed ID: 9473218
[TBL] [Abstract][Full Text] [Related]
2. Protein C inhibitor is a potent inhibitor of the thrombin-thrombomodulin complex.
Rezaie AR; Cooper ST; Church FC; Esmon CT
J Biol Chem; 1995 Oct; 270(43):25336-9. PubMed ID: 7592694
[TBL] [Abstract][Full Text] [Related]
3. Protein C inhibitor regulates the thrombin-thrombomodulin complex in the up- and down regulation of TAFI activation.
Mosnier LO; Elisen MG; Bouma BN; Meijers JC
Thromb Haemost; 2001 Oct; 86(4):1057-64. PubMed ID: 11686324
[TBL] [Abstract][Full Text] [Related]
4. Platelet factor 4 inhibits thrombomodulin-dependent activation of thrombin-activatable fibrinolysis inhibitor (TAFI) by thrombin.
Mosnier LO
J Biol Chem; 2011 Jan; 286(1):502-10. PubMed ID: 21041299
[TBL] [Abstract][Full Text] [Related]
5. Thrombomodulin in human plasma contributes to inhibit fibrinolysis through acceleration of thrombin-dependent activation of plasma procarboxypeptidase B.
Hosaka Y; Takahashi Y; Ishii H
Thromb Haemost; 1998 Feb; 79(2):371-7. PubMed ID: 9493593
[TBL] [Abstract][Full Text] [Related]
6. Evidence that the protein C activation pathway amplifies the inhibition of thrombin generation by recombinant human thrombomodulin in plasma.
Ohishi R; Watanabe N; Aritomi M; Gomi K; Kiyota T; Yamamoto S; Ishida T; Maruyama I
Thromb Haemost; 1993 Sep; 70(3):423-6. PubMed ID: 8259542
[TBL] [Abstract][Full Text] [Related]
7. Use of annexin-V to demonstrate the role of phosphatidylserine exposure in the maintenance of haemostatic balance by endothelial cells.
Ravanat C; Archipoff G; Beretz A; Freund G; Cazenave JP; Freyssinet JM
Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):7-13. PubMed ID: 1311563
[TBL] [Abstract][Full Text] [Related]
8. Elevated thrombin-forming capacity of tissue factor-activated cord compared with adult plasma.
Cvirn G; Gallistl S; Rehak T; Jürgens G; Muntean W
J Thromb Haemost; 2003 Aug; 1(8):1785-90. PubMed ID: 12911594
[TBL] [Abstract][Full Text] [Related]
9. Protein C inhibitor directly and potently inhibits activated hepatocyte growth factor activator.
Hayashi T; Nishioka J; Nakagawa N; Kamada H; Gabazza EC; Kobayashi T; Hattori A; Suzuki K
J Thromb Haemost; 2007 Jul; 5(7):1477-85. PubMed ID: 17456194
[TBL] [Abstract][Full Text] [Related]
10. Effects of recombinant human soluble thrombomodulin (rhs-TM) on clot-induced coagulation in human plasma.
Mohri M; Suzuki M; Sugimoto E; Sata M; Yamamoto S; Maruyama I
Thromb Haemost; 1998 Dec; 80(6):925-9. PubMed ID: 9869162
[TBL] [Abstract][Full Text] [Related]
11. Host protein C inhibitor inhibits tumor growth, but promotes tumor metastasis, which is closely correlated with hypercoagulability.
Akita N; Ma N; Okamoto T; Asanuma K; Yoshida K; Nishioka J; Shimaoka M; Suzuki K; Hayashi T
Thromb Res; 2015 Jun; 135(6):1203-8. PubMed ID: 25887633
[TBL] [Abstract][Full Text] [Related]
12. Increased anticoagulant activity of recombinant thrombomodulin modified with glycosaminoglycan.
Edano T; Inoue K; Yoshizaki H; Yamamoto S; Komine N; Tabunoki H; Sawada H; Koshi T; Murakami A; Wada Y; Ohkuchi M
Biol Pharm Bull; 1998 Apr; 21(4):375-81. PubMed ID: 9586576
[TBL] [Abstract][Full Text] [Related]
13. Essential thrombin residues for inhibition by protein C inhibitor with the cofactors heparin and thrombomodulin.
Fortenberry YM; Whinna HC; Cooper ST; Myles T; Leung LL; Church FC
J Thromb Haemost; 2007 Jul; 5(7):1486-92. PubMed ID: 17635698
[TBL] [Abstract][Full Text] [Related]
14. The technique of measuring thrombin generation with fluorogenic substrates: 3. The effects of sample dilution.
De Smedt E; Wagenvoord R; Coen Hemker H
Thromb Haemost; 2009 Jan; 101(1):165-70. PubMed ID: 19132204
[TBL] [Abstract][Full Text] [Related]
15. Protein C inhibitor as an anti-disseminated intravascular coagulation agent--mechanism and modification.
Fujita M; Izutani W; Takahashi K
Curr Med Chem Cardiovasc Hematol Agents; 2004 Jan; 2(1):21-7. PubMed ID: 15320803
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory mechanism of the protein C pathway on tissue factor-induced thrombin generation. Synergistic effect in combination with tissue factor pathway inhibitor.
van 't Veer C; Golden NJ; Kalafatis M; Mann KG
J Biol Chem; 1997 Mar; 272(12):7983-94. PubMed ID: 9065469
[TBL] [Abstract][Full Text] [Related]
17. Thrombomodulin accelerates activated protein C production and inhibits thrombin generation in the plasma of disseminated intravascular coagulation patients.
Wada H; Sakakura M; Kushiya F; Nisikawa M; Onishi K; Nakatani K; Shiku H; Nobori T
Blood Coagul Fibrinolysis; 2005 Jan; 16(1):17-24. PubMed ID: 15650541
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of thrombin generation by protein S at low procoagulant stimuli: implications for maintenance of the hemostatic balance.
Seré KM; Rosing J; Hackeng TM
Blood; 2004 Dec; 104(12):3624-30. PubMed ID: 15292065
[TBL] [Abstract][Full Text] [Related]
19. Basic residues in the 37-loop of activated protein C modulate inhibition by protein C inhibitor but not by alpha(1)-antitrypsin.
Glasscock LN; Gerlitz B; Cooper ST; Grinnell BW; Church FC
Biochim Biophys Acta; 2003 Jun; 1649(1):106-17. PubMed ID: 12818196
[TBL] [Abstract][Full Text] [Related]
20. Visualization of Domain- and Concentration-Dependent Impact of Thrombomodulin on Differential Regulation of Coagulation and Fibrinolysis.
Mochizuki L; Sano H; Honkura N; Masumoto K; Urano T; Suzuki Y
Thromb Haemost; 2023 Jan; 123(1):16-26. PubMed ID: 36307100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
